U.S Urology Partners announced today that David M. Albala, M.D., has joined its Board of Directors. A board certified urologist considered an authority in laparoscopic and robotic urological surgery, Dr. Albala is internationally recognized for his decades of leadership in the field of urology. His contributions include being part of the team that performed the first laparoscopic nephrectomy in humans. An educator and researcher with 160 publications in peer-reviewed journals and 6 books, Dr. Albala’s experience includes operative demonstrations in more than 30 countries in addition to serving as a White House Fellow.
U.S. Urology Partners is one of the nation’s largest independent providers of urological and related specialty services, including general urology, surgical procedures, advanced treatment options for prostate and bladder cancer, and other ancillary services. Through its operations with Central Ohio Urology Group and recently announced partnership with Associated Medical Professionals of New York, the clinical network of U.S. Urology Partners now consists of 24 locations in the Ohio and Upstate New York regions.
Mark Cherney, Chief Executive Officer of U.S. Urology Partners, stated, “We are thrilled with Dr. David Albala joining the U.S. Urology Partners board alongside Dr. Angelo DeRosalia, his partner at Associated Medical Professionals of NY. David’s expertise and knowledge of the U.S. urology marketplace will be helpful as we continue to build our presence.”
U.S. Urology Partners was formed in 2018 to support urology practices through an experienced team of healthcare executives and resources, while serving as a platform upon which the company’s investment partner, NMS Capital, intends to build a leading provider of urological services through an acquisition strategy.
Angelo R. DeRosalia, M.D., President of U.S. Urology Partners, and Chairman and Chief Executive Officer of Associated Medical Professionals of NY, said, “Dr. Albala is a great addition to the U.S. Urology Partners board. His decades of experience and wealth of knowledge will undoubtedly serve U.S. Urology Partners well as we move forward in the future.”
David M. Albala, M.D., stated, “I am looking forward to working with U.S. Urology Partners. I believe my experience in academic urology at both Loyola University and Duke University will provide a different perspective, especially on incorporating cutting edge technology in the private sector.”
Dr. David M. Albala is a board certified urologist who is fellowship-trained in endourology, laparoscopy and robotic surgery. He graduated with a geology degree from Lafayette College in Easton, Pennsylvania. He completed his medical school training at Michigan State University and went on to complete his surgical residency at the Dartmouth-Hitchcock Medical Center. Following this, Dr. Albala was an endourology fellow at Washington University Medical Center in St. Louis, Missouri, under the direction of Ralph V. Clayman. At Washington University, he was part of the team that performed the first laparoscopic nephrectomy in humans. He practiced at Loyola University Medical Center in Chicago and rose from the ranks of Instructor to Full Professor in Urology and Radiology in 8 years. After 10 years at Loyola, he became a tenured Professor of Surgery (Urology) at Duke University in Durham, North Carolina. At Duke, he was Co-Director of the Endourology fellowship and the Director for the Center of Minimally Invasive and Robotic Urological Surgery. He has overall 160 publications in peer-reviewed journals and has authored 3 textbooks in endourology and 3 books in general urology. He is currently the Editor-in-Chief of the Journal of Robotic Surgery and serves on the editorial board for Current Opinions in Urology, Reviews in Urology, and Urology Index and Reviews. In addition, he serves as a reviewer for 8 other surgical journals. He is currently on the Board of Directors of the Large Urology Group Practice Association (LUGPA). LUGPA is the only nonprofit urology trade association that represents over 25% of practicing urologists in the United States.
At the present time, he is Chief of Urology at Crouse Hospital in Syracuse, New York. He is considered a national and international authority in laparoscopic and robotic urological surgery and has been an active teacher in this area for over 20 years. His research and clinical interest have focused on robotic urologic surgery. In addition, other clinical interest includes minimally invasive treatments for benign prostatic hypertrophy (BPH) and the use of fibrin sealants in surgery. He has been a Visiting Professor at numerous institutions across the United States as well as overseas in countries such as India, China, Iceland, Germany, France, Japan, Brazil, Australia and Singapore. He has done operative demonstrations in over 32 countries and 23 states. He has trained 16 fellows in endourology and advanced robotic surgery.
Dr. Albala is a past White House Fellow (1995-1996), who acted as a special assistant to Federico Peña, Secretary of Transportation, on classified and unclassified public health related issues.
About U.S. Urology Partners
U.S. Urology Partners is one of the nation’s largest independent providers of urology and related specialty services, including general urology, surgical procedures, advanced treatment options for prostate and bladder cancer, and other ancillary services. Through Central Ohio Urology Group and Associated Medical Professionals of NY, the U.S. Urology Partners practice now consists of more than 50 providers across a network of 24 offices throughout Ohio and Upstate New York, including a state-of-the-art ambulatory surgery center. U.S. Urology Partners was formed to support urology practices through an experienced team of healthcare executives and resources, while serving as a platform upon which NMS Capital intends to build a leading provider of urological services through an acquisition strategy. The U.S. Urology Partners corporate offices are in Gahanna, Ohio, and Nolensville, Tennessee, just outside of Columbus and Nashville. For additional information on U.S. Urology Partners, please visit the company’s website at www.us-uro.com.